Gigaxonin-controlled degradation of MAP1B light chain is critical to neuronal survival

Nature

Volumn 438, Issue 7065, 2005, Pages 224-228

  Allen, Elizabeth ^a   Ding, Jianqing ^a   Wang, Wei ^a   Pramanik, Suneet ^a   Chou, Jonathan ^a   Yau, Vincent ^a   Yang, Yanmin ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGGLOMERATION; BIODEGRADATION; PATHOLOGY; PROTEINS;

CYTOSKELETAL COMPONENTS; GIGAZONIN-CONTROLLED NEUROPATHY (GAN); LIGHT CHAIN (LC);

NEUROLOGY;

GIGAXONIN; MICROTUBULE ASSOCIATED PROTEIN 5; PROTEASOME INHIBITOR; PROTEIN; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG;

NEUROLOGY;

ARTICLE; BRAIN CELL; CARBOXY TERMINAL SEQUENCE; CELL DEATH; CELL SURVIVAL; DEGENERATIVE DISEASE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LIGHT CHAIN; NULL ALLELE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN DOMAIN; SURVIVAL RATE;

EID: 27744494043     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature04256     Document Type: Article

References (25)

1. Bomont, P. et al. The gene encoding gigaxonin, a new member of the cytoskeletal BTB/kelch repeat family, is mutated in giant axonal neuropathy. Nature Genet. 26, 370-374 (2000).
2. Bomont, P. et al. Identification of seven novel mutations in the GAN gene. Hum. Mutat. 21, 446 (2003).
3. Tazir, M. et al. Genetic heterogeneity in giant axonal neuropathy: an Algerian family not linked to chromosome 16q24.1. Neuromuscul. Disord. 12, 849-852 (2002).
4. Bruno, C. et al. Clinical and molecular findings in patients with giant axonal neuropathy (GAN). Neurology 62, 13-16 (2004).
5. Timmerman, V., De Jonghe, P. & Van Broeckhoven, C. Of giant axons and curly hair. Nature Genet. 26, 254-255 (2000).
6. Tandan, R. et al. Childhood giant axonal neuropathy. Case report and review of the literature. J. Neurol. Sci. 82, 205-228 (1987).
7. Lampl, Y. et al. Giant axonal neuropathy with predominant central nervous system manifestations. Dev. Med. Child Neurol. 34, 164-169 (1992).
8. Ding, J. et al. Microtubule-associated protein 1B: a neuronal binding partner for gigaxonin. J. Cell Biol. 158, 427-433 (2002).
9. Pintard, L. et al. The BTB protein MEL-26 is a substrate-specific adaptor of the CUL-3 ubiquitin-ligase. Nature 425, 311-316 (2003).
10. van den Heuvel, S. Protein degradation: CUL-3 and BTB-partners in proteolysis. Curr. Biol. 14, R59-R61 (2004).
11. Geyer, R., Wee, S., Anderson, S., Yates, J. & Wolf, D. A. BTB/POZ domain proteins are putative substrate adaptors for cullin 3 ubiquitin ligases. Mol. Cell 12, 783-790 (2003).
12. Furukawa, M., He, Y. J., Borchers, C. & Xiong, Y. Targeting of protein ubiquitination by BTB-Cullin 3-Roc1 ubiquitin ligases. Nature Cell Biol. 5, 1001-1007 (2003).
13. Ehlers, M. D. Deconstructing the axon: Wallerian degeneration and the ubiquitin-proteasome system. Trends Neurosci. 27, 3-6 (2004).
14. Zhai, Q. et al. Involvement of the ubiquitin-proteasome system in the early stages of wallerian degeneration. Neuron 39, 217-225 (2003).
15. Watts, R. J., Hoopfer, E. D. & Luo, L. Axon pruning during Drosophila metamorphosis: evidence for local degeneration and requirement of the ubiquitin-proteasome system. Neuron 38, 871-885 (2003).
16. Mei, X., Sweatt, A. J. & Hammarback, J. A. Regulation of microtubule-associated protein 1B (MAP1B) subunit composition. J. Neurosci. Res. 62, 56-64 (2000).
17. Edelmann, W. et al. Neuronal abnormalities in microtubule-associated protein 1B mutant mice. Proc. Natl Acad. Sci. USA 93, 1270-1275 (1996).
18. Tucker, R. P. & Matus, A. I. Developmental regulation of two microtubule-associated proteins (MAP2 and MAP5) in the embryonic avian retina. Development 101, 535-546 (1987).
19. Lu, R. et al. The fragile X protein controls microtubule-associated protein 1B translation and microtubule stability in brain neuron development. Proc. Natl Acad. Sci. USA 101, 15201-15206 (2004).
20. Lopez, L. A. & Sheetz, M. P. Steric inhibition of cytoplasmic dynein and kinesin motility by MAP2. Cell Motil. Cytoskeleton 24, 1-16 (1993).
21. Paschal, B. M., Obar, R. A. & Vallee, R. B. Interaction of brain cytoplasmic dynein and MAP2 with a common sequence at the C terminus of tubulin. Nature 342, 569-572 (1989).
22. Hagiwara, H., Yorifuji, H., Sato-Yoshitake, R. & Hirokawa, N. Competition between motor molecules (kinesin and cytoplasmic dynein) and fibrous microtubule-associated proteins in binding to microtubules. J. Biol. Chem. 269, 3581-3589 (1994).
23. von Massow, A., Mandelkow, E. M. & Mandelkow, E. Interaction between kinesin, microtubules, and microtubule-associated protein 2. Cell Motil. Cytoskeleton 14, 562-571 (1989).
24. Vicario-Abejón, C. in Current Protocols in Neuroscience (eds Crawley, J. N. et al.) Ch. 3, 2.1-2.13 (John Wiley & Sons, Somerset, New Jersey, 2004).
25. Togel, M., Wiche, G. & Propst, F. Novel features of the light chain of microtubule-associated protein MAP1B: microtubule stabilization, self interaction, actin filament binding, and regulation by the heavy chain. J. Cell Biol. 143, 695-707 (1998).